Table 2 Comparison of Cas9–HE and Cas9 in obtaining targeted transgene integration into the rat Rosa26 and Il22bp loci
From: CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
Cas9 form | Target locus | KI fragments | Dose Cas9 mRNA/sgRNA/donor DNA (ng/µl) | Eggs injected (survival rate %) | Eggs transferred | E14 embryos (% transferred) | Indels + (% of E14) | Donor integration+ (% of E14) | HDR+ (% of E14) |
---|---|---|---|---|---|---|---|---|---|
Cas9–HE | Rosa26 | CAG-GFP | 50/10/2 | 216 (75%) | 154 | 37 (24%) | 29 (78%) | 5 (13%) | 3 (8%) |
Cas9 | Rosa26 | CAG-GFP | 50/10/2 | 284 (77%) | 211 | 84 (39%) | 62 (73%) | 2 (2%) | 1 (1%) |
Cas9–HE | Il22bp | Il22bp-2A-GFP | 50/10/2 | 277 (78%) | 217 | 82 (37%) | 45 (55%) | 7 (8%) | 2 (2%) |
Cas9 | Il22bp | Il22bp-2A-GFP | 50/10/2 | 286 (80%) | 226 | 91 (40%) | 55 (60%) | 8 (8%) | 4 (4%) |